Abstract
BackgroundUse of Hydroxychloroquine (HCQ) is known to be associated with less disease activity, flares, damage and better survival in patients with Systemic Lupus Erythematosus (SLE). It is not known if...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have